Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJK3D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,829
Award facts
- Contract value 100% obligated
- $11,829.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $11,829.08 delivery order to Amerisourcebergen Drug Corp on January 27, 2026, for RINVOQ ER 30 mg tablets (30-count unit dose).
The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order carries a firm fixed price structure and an ultimate completion date of January 28, 2026.
Quick answers
Who was awarded contract SPE2DR26FJK3D?
SPE2DR26FJK3D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FJK3D worth?
The government has obligated $11,829 on SPE2DR26FJK3D.
Is contract SPE2DR26FJK3D an order under another contract?
Yes. SPE2DR26FJK3D is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK3D competed?
The extent of competition for SPE2DR26FJK3D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award